These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17639215)

  • 21. Issues facing TB control (7). Multiple drug-resistant tuberculosis.
    Raviglione MC
    Scott Med J; 2000 Oct; 45(5 Suppl):52-5; discussion 56. PubMed ID: 11130318
    [No Abstract]   [Full Text] [Related]  

  • 22. Joint efforts urgently needed at times of emerging tuberculosis drug resistance.
    Allerberger F; Cambau E; Lange C
    Clin Microbiol Infect; 2017 Mar; 23(3):129-130. PubMed ID: 27592088
    [No Abstract]   [Full Text] [Related]  

  • 23. Picking up the pace--scale-up of MDR tuberculosis treatment programs.
    Keshavjee S; Farmer PE
    N Engl J Med; 2010 Nov; 363(19):1781-4. PubMed ID: 21047219
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of tuberculosis control programme in Khartoum State for the year 2006.
    Ahmed Suleiman MM; Aro AR; Sodemann M
    Scand J Public Health; 2009 Jan; 37(1):101-8. PubMed ID: 19141559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extensively drug-resistant tuberculosis. Recent outbreaks highlight the need for improved prevention, control, and surveillance programs.
    Todd B
    Am J Nurs; 2007 Jun; 107(6):29-31. PubMed ID: 17519597
    [No Abstract]   [Full Text] [Related]  

  • 26. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global scale-up of the programmatic management of multidrug-resistant tuberculosis.
    Daley CL
    Indian J Tuberc; 2014 Apr; 61(2):108-15. PubMed ID: 25509932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global Tuberculosis Control: Toward the 2015 Targets and Beyond.
    Dirlikov E; Raviglione M; Scano F
    Ann Intern Med; 2015 Jul; 163(1):52-8. PubMed ID: 25915859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies for control of tuberculosis.
    Marshall BG; Coker RJ
    Lancet; 1997 Mar; 349(9055):882-3. PubMed ID: 9121289
    [No Abstract]   [Full Text] [Related]  

  • 30. Tackling the spread of drug-resistant tuberculosis in Europe.
    Abubakar I; Dara M; Manissero D; Zumla A
    Lancet; 2012 Jan; 379(9813):e21-3. PubMed ID: 21924489
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.
    Fears R; Kaufmann S; Ter Meulen V; Zumla A;
    Tuberculosis (Edinb); 2010 May; 90(3):182-7. PubMed ID: 20382566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuberculosis control goals unlikely to be met by 2005.
    Sharma DC
    Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013
    [No Abstract]   [Full Text] [Related]  

  • 33. Low-income countries: where are we going with TB-HIV in 2009?
    Mwinga A
    Int J Tuberc Lung Dis; 2009 Jul; 13(7):797-8. PubMed ID: 19555525
    [No Abstract]   [Full Text] [Related]  

  • 34. [Fight against tuberculosis in the world].
    El Kamel A; Joobeur S; Skhiri N; Cheikh Mhamed S; Mribah H; Rouatbi N
    Rev Pneumol Clin; 2015; 71(2-3):181-7. PubMed ID: 24878188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 'bear trap': the colliding epidemics of tuberculosis and HIV in Russia.
    Drobniewski FA; Atun R; Fedorin I; Bikov A; Coker R
    Int J STD AIDS; 2004 Oct; 15(10):641-6. PubMed ID: 15479497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining priorities: swine-origin H1N1 and the MDR-TB epidemic.
    Migliori GB; Sotgiu G; Lange C; Macgregor-Skinner G
    Lancet; 2009 Jun; 373(9681):2108. PubMed ID: 19541029
    [No Abstract]   [Full Text] [Related]  

  • 37. Carpe diem ('Seize the day'): Building on the findings of the 2015 World Health Organization evaluation of the multidrug-resistant tuberculosis (MDR-TB) programme to make the most of shortened MDR-TB treatment in South Africa.
    Loveday M; Cox H
    S Afr Med J; 2017 Feb; 107(3):176-177. PubMed ID: 28281418
    [No Abstract]   [Full Text] [Related]  

  • 38. [Multidrug-resistant tuberculosis. 5. Human immunodeficiency virus infection and multidrug-resistant tuberculosis].
    Fujita A
    Kekkaku; 1998 Nov; 73(11):679-85. PubMed ID: 9866931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug-resistant tuberculosis: many paths, same truth.
    Fujiwara PI; Sherman LF
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):297-8. PubMed ID: 9432382
    [No Abstract]   [Full Text] [Related]  

  • 40. Issues facing TB control (6). Tuberculosis control in sub-Saharan Africa in the face of HIV and AIDS.
    Harries AD
    Scott Med J; 2000 Oct; 45(5 Suppl):47-50; discussion 51. PubMed ID: 11130317
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.